1. Cholecystectomy for mild gallstone pancreatitis
2. Exclusion criteria and the effect on adenoma detection rate
3. Risk factors for prediction of cancer after initial colonoscopy
4. Clopidogrel with proton pump inhibitors
5. Weight loss and nonalcoholic steatohepatitis
6. Long-term safety of PPI therapy
7. Grazoprevir-Elbasvir combination therapy for HCV
8. Fecal microbiota transplantation for Clostridium difficile
9. Barrett’s esophagus diagnosis and management
10. Hepatitis B reactivation during immunosuppressive drug therapy
More articles on gastroenterology:
EndoChoice receives “strong buy” rating from analysts: 4 points
FDA warns against use of AbbVie’s hepatitis C treatments: 5 key notes
5 most-read GI/endoscopy stories: Week of Dec. 21 – Dec. 25
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.